2024-01-012024-12-312024-12-31false09754607PRIME MEDICAL STAFFING LIMITED2025-09-23falseiso4217:GBPxbrli:pure097546072023-12-31097546072024-12-31097546072024-01-012024-12-31097546072022-12-31097546072023-12-31097546072023-01-012023-12-3109754607bus:SmallEntities2024-01-012024-12-3109754607bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3109754607bus:FullAccounts2024-01-012024-12-3109754607bus:PrivateLimitedCompanyLtd2024-01-012024-12-3109754607core:WithinOneYear2024-12-3109754607core:AfterOneYear2024-12-3109754607core:WithinOneYear2023-12-3109754607core:AfterOneYear2023-12-3109754607core:ShareCapital2024-12-3109754607core:SharePremium2024-12-3109754607core:RevaluationReserve2024-12-3109754607core:OtherReservesSubtotal2024-12-3109754607core:RetainedEarningsAccumulatedLosses2024-12-3109754607core:ShareCapital2023-12-3109754607core:SharePremium2023-12-3109754607core:RevaluationReserve2023-12-3109754607core:OtherReservesSubtotal2023-12-3109754607core:RetainedEarningsAccumulatedLosses2023-12-3109754607core:LandBuildings2024-12-3109754607core:PlantMachinery2024-12-3109754607core:Vehicles2024-12-3109754607core:FurnitureFittings2024-12-3109754607core:OfficeEquipment2024-12-3109754607core:NetGoodwill2024-12-3109754607core:IntangibleAssetsOtherThanGoodwill2024-12-3109754607core:ListedExchangeTraded2024-12-3109754607core:UnlistedNon-exchangeTraded2024-12-3109754607core:LandBuildings2023-12-3109754607core:PlantMachinery2023-12-3109754607core:Vehicles2023-12-3109754607core:FurnitureFittings2023-12-3109754607core:OfficeEquipment2023-12-3109754607core:NetGoodwill2023-12-3109754607core:IntangibleAssetsOtherThanGoodwill2023-12-3109754607core:ListedExchangeTraded2023-12-3109754607core:UnlistedNon-exchangeTraded2023-12-3109754607core:LandBuildings2024-01-012024-12-3109754607core:PlantMachinery2024-01-012024-12-3109754607core:Vehicles2024-01-012024-12-3109754607core:FurnitureFittings2024-01-012024-12-3109754607core:OfficeEquipment2024-01-012024-12-3109754607core:NetGoodwill2024-01-012024-12-3109754607core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109754607core:ListedExchangeTraded2024-01-012024-12-3109754607core:UnlistedNon-exchangeTraded2024-01-012024-12-3109754607core:MoreThanFiveYears2024-01-012024-12-3109754607core:Non-currentFinancialInstruments2024-12-3109754607core:Non-currentFinancialInstruments2023-12-3109754607dpl:CostSales2024-01-012024-12-3109754607dpl:DistributionCosts2024-01-012024-12-3109754607core:LandBuildings2024-01-012024-12-3109754607core:PlantMachinery2024-01-012024-12-3109754607core:Vehicles2024-01-012024-12-3109754607core:FurnitureFittings2024-01-012024-12-3109754607core:OfficeEquipment2024-01-012024-12-3109754607dpl:AdministrativeExpenses2024-01-012024-12-3109754607core:NetGoodwill2024-01-012024-12-3109754607core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109754607dpl:GroupUndertakings2024-01-012024-12-3109754607dpl:ParticipatingInterests2024-01-012024-12-3109754607dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3109754607core:ListedExchangeTraded2024-01-012024-12-3109754607dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3109754607core:UnlistedNon-exchangeTraded2024-01-012024-12-3109754607dpl:CostSales2023-01-012023-12-3109754607dpl:DistributionCosts2023-01-012023-12-3109754607core:LandBuildings2023-01-012023-12-3109754607core:PlantMachinery2023-01-012023-12-3109754607core:Vehicles2023-01-012023-12-3109754607core:FurnitureFittings2023-01-012023-12-3109754607core:OfficeEquipment2023-01-012023-12-3109754607dpl:AdministrativeExpenses2023-01-012023-12-3109754607core:NetGoodwill2023-01-012023-12-3109754607core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3109754607dpl:GroupUndertakings2023-01-012023-12-3109754607dpl:ParticipatingInterests2023-01-012023-12-3109754607dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3109754607core:ListedExchangeTraded2023-01-012023-12-3109754607dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3109754607core:UnlistedNon-exchangeTraded2023-01-012023-12-3109754607core:NetGoodwill2024-12-3109754607core:IntangibleAssetsOtherThanGoodwill2024-12-3109754607core:LandBuildings2024-12-3109754607core:PlantMachinery2024-12-3109754607core:Vehicles2024-12-3109754607core:FurnitureFittings2024-12-3109754607core:OfficeEquipment2024-12-3109754607core:AfterOneYear2024-12-3109754607core:WithinOneYear2024-12-3109754607core:ListedExchangeTraded2024-12-3109754607core:UnlistedNon-exchangeTraded2024-12-3109754607core:ShareCapital2024-12-3109754607core:SharePremium2024-12-3109754607core:RevaluationReserve2024-12-3109754607core:OtherReservesSubtotal2024-12-3109754607core:RetainedEarningsAccumulatedLosses2024-12-3109754607core:NetGoodwill2023-12-3109754607core:IntangibleAssetsOtherThanGoodwill2023-12-3109754607core:LandBuildings2023-12-3109754607core:PlantMachinery2023-12-3109754607core:Vehicles2023-12-3109754607core:FurnitureFittings2023-12-3109754607core:OfficeEquipment2023-12-3109754607core:AfterOneYear2023-12-3109754607core:WithinOneYear2023-12-3109754607core:ListedExchangeTraded2023-12-3109754607core:UnlistedNon-exchangeTraded2023-12-3109754607core:ShareCapital2023-12-3109754607core:SharePremium2023-12-3109754607core:RevaluationReserve2023-12-3109754607core:OtherReservesSubtotal2023-12-3109754607core:RetainedEarningsAccumulatedLosses2023-12-3109754607core:NetGoodwill2022-12-3109754607core:IntangibleAssetsOtherThanGoodwill2022-12-3109754607core:LandBuildings2022-12-3109754607core:PlantMachinery2022-12-3109754607core:Vehicles2022-12-3109754607core:FurnitureFittings2022-12-3109754607core:OfficeEquipment2022-12-3109754607core:AfterOneYear2022-12-3109754607core:WithinOneYear2022-12-3109754607core:ListedExchangeTraded2022-12-3109754607core:UnlistedNon-exchangeTraded2022-12-3109754607core:ShareCapital2022-12-3109754607core:SharePremium2022-12-3109754607core:RevaluationReserve2022-12-3109754607core:OtherReservesSubtotal2022-12-3109754607core:RetainedEarningsAccumulatedLosses2022-12-3109754607core:AfterOneYear2024-01-012024-12-3109754607core:WithinOneYear2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754607core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3109754607core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3109754607core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3109754607core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3109754607core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3109754607bus:Director12024-01-012024-12-3109754607bus:Director22024-01-012024-12-31

PRIME MEDICAL STAFFING LIMITED

Registered Number
09754607
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

PRIME MEDICAL STAFFING LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

Mark Burrell
Natasha Lillian Hoskins

Registered Address

214 Grangewood House 43 Oakwood Hill
Loughton
IG10 3TZ

Registered Number

09754607 (England and Wales)
PRIME MEDICAL STAFFING LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors-10,704
Cash at bank and on hand-15
-10,719
Creditors amounts falling due within one year3(154,389)(114,599)
Net current assets (liabilities)(154,389)(103,880)
Total assets less current liabilities(154,389)(103,880)
Creditors amounts falling due after one year4(4,834)(15,390)
Net assets(159,223)(119,270)
Capital and reserves
Called up share capital44
Profit and loss account(159,227)(119,274)
Shareholders' funds(159,223)(119,270)
The financial statements were approved and authorised for issue by the Board of Directors on 23 September 2025, and are signed on its behalf by:
Mark Burrell
Director
Registered Company No. 09754607
PRIME MEDICAL STAFFING LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognized by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Defined contribution pension plan
Contributions to defined contribution plans are expensed in the period to which they relate.
2.Average number of employees

20242023
Average number of employees during the year22
3.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-2,128
Bank borrowings and overdrafts10,55720,411
Other creditors143,83292,060
Total154,389114,599
4.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts4,83415,390
Total4,83415,390